Literature DB >> 23668772

Clinical, metabolic and psychological outcomes and treatment costs of a prospective randomized trial based on different educational strategies to improve diabetes care (PRODIACOR).

J J Gagliardino1, S Lapertosa, G Pfirter, M Villagra, J E Caporale, C D Gonzalez, J Elgart, L González, C Cernadas, E Rucci, C Clark.   

Abstract

AIM: To evaluate the effect of system interventions (formalized data collection and 100% coverage of medications and supplies) combined with physician and/or patient education on therapeutic indicators and costs in Type 2 diabetes.
METHODS: This was a randomized 2 × 2 design in public health, social security or private prepaid primary care clinics in Corrientes, Argentina. Thirty-six general practitioners and 468 adults with Type 2 diabetes participated. Patients of nine participating physicians were selected randomly and assigned to one of four structured group education programmes (117 patients each): control (group 1), physician education (group 2), patient education (group 3), and both physician education and patient education (group 4), with identical system interventions in all four groups. Outcome measures included HbA(1c), BMI, blood pressure, fasting glucose, lipid profile, drug consumption, resource use and patient well-being at baseline and every 6 months up to 42 months.
RESULTS: HbA(1c) decreased significantly from 4 mmol/mol to 10 mmol/mol by 42 months (P < 0.05); the largest and more consistent decrease was in the groups where patients and physicians were educated. Blood pressure and triglycerides decreased significantly in all groups; the largest changes were recorded in the combined education group. The World Health Organization-5 Lowe score showed significant improvements, without differences among groups. The lowest treatment cost was seen in the combined education group.
CONCLUSIONS: In a primary care setting, educational interventions combined with comprehensive care coverage resulted in long-term improvement in clinical, metabolic and psychological outcomes at the best cost-effectiveness ratio.
© 2013 The Authors. Diabetic Medicine © 2013 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23668772     DOI: 10.1111/dme.12230

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  14 in total

1.  Evidence based review of type 2 diabetes prevention and management in low and middle income countries.

Authors:  Aimee Afable; Nidhi Shree Karingula
Journal:  World J Diabetes       Date:  2016-05-25

2.  Direct and indirect costs associated to type 2 diabetes and its complications measured in a social security institution of Argentina.

Authors:  Jorge F Elgart; Santiago Asteazarán; Jorge L De La Fuente; Cecilia Camillucci; Jonathan B Brown; Juan José Gagliardino
Journal:  Int J Public Health       Date:  2014-09-05       Impact factor: 3.380

Review 3.  Aspects of Multicomponent Integrated Care Promote Sustained Improvement in Surrogate Clinical Outcomes: A Systematic Review and Meta-analysis.

Authors:  Lee Ling Lim; Eric S H Lau; Alice P S Kong; Melanie J Davies; Naomi S Levitt; Björn Eliasson; Carlos A Aguilar-Salinas; Guang Ning; Yutaka Seino; Wing Yee So; Margaret McGill; Graham D Ogle; Trevor J Orchard; Philip Clarke; Rury R Holman; Edward W Gregg; Juan José Gagliardino; Juliana C N Chan
Journal:  Diabetes Care       Date:  2018-06       Impact factor: 19.112

Review 4.  Diabetes self-management education reduces risk of all-cause mortality in type 2 diabetes patients: a systematic review and meta-analysis.

Authors:  Xiaoqin He; Jie Li; Bin Wang; Qiuming Yao; Ling Li; Ronghua Song; Xiaohong Shi; Jin-An Zhang
Journal:  Endocrine       Date:  2016-11-12       Impact factor: 3.633

5.  One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS).

Authors:  Juliana C N Chan; Juan José Gagliardino; Hasan Ilkova; Fernando Lavalle; Ambady Ramachandran; Jean Claude Mbanya; Marina Shestakova; Cecile Dessapt-Baradez; Jean-Marc Chantelot; Pablo Aschner
Journal:  Adv Ther       Date:  2021-05-12       Impact factor: 3.845

Review 6.  Lifestyle Interventions to Improve Glycemic Control in Adults with Type 2 Diabetes Living in Low-and-Middle Income Countries: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs).

Authors:  Grainne O'Donoghue; Cliona O'Sullivan; Isabelle Corridan; Jennifer Daly; Ronan Finn; Kathryn Melvin; Casey Peiris
Journal:  Int J Environ Res Public Health       Date:  2021-06-10       Impact factor: 3.390

Review 7.  Diabetes in Argentina: cost and management of diabetes and its complications and challenges for health policy.

Authors:  Joaquín E Caporale; Jorge F Elgart; Juan J Gagliardino
Journal:  Global Health       Date:  2013-10-29       Impact factor: 4.185

8.  Type 2 diabetes family histories, body composition and fasting glucose levels: a cross-section analysis in healthy sedentary male and female.

Authors:  Antonino Bianco; Francesco Pomara; Ewan Thomas; Antonio Paoli; Giuseppe Battaglia; Marco Petrucci; Patrizia Proia; Marianna Bellafiore; Antonio Palma
Journal:  Iran J Public Health       Date:  2013-07-01       Impact factor: 1.429

9.  Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data.

Authors:  Bruno Linetzky; Brad Curtis; Gustavo Frechtel; Renan Montenegro; Miguel Escalante Pulido; Oded Stempa; Janaina Martins de Lana; Juan José Gagliardino
Journal:  Diabetol Metab Syndr       Date:  2016-07-22       Impact factor: 3.320

10.  The complex scenario of obesity, diabetes and hypertension in the area of influence of primary healthcare facilities in Mexico.

Authors:  J E Alcalde-Rabanal; E Orozco-Núñez; O E Espinosa-Henao; A Arredondo-López; L Alcayde-Barranco
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.